Kaplan-Meier curves for EFS according to TPMT status (homozygous mutant plus heterozygotes versus homozygous wild-type phenotype), indicating a tendency for better outcome among those with TPMT defects (P = .096) in a multivariate model in which dose intensity for 6MP was the most important predictor (P = .022).